What is Thymia?
Thymia is at the forefront of health technology, leveraging advanced gamified AI to diagnose and monitor mental health conditions. By analyzing voice, movement, and behavioral data, Thymia provides objective insights into symptoms of mental illness. This innovative approach aims to revolutionize how mental health is assessed, offering a more accessible and data-driven alternative to traditional methods. The company's focus on early detection and continuous monitoring positions it as a key player in the digital health sector.
How much funding has Thymia raised?
Thymia has raised a total of $2.7M across 1 funding round:
Angel/Seed
$2.7M
Angel/Seed (2023): $2.7M with participation from Entrepreneur First and Form Ventures
Key Investors in Thymia
Entrepreneur First
Entrepreneur First is an international Talent Investor that supports individuals in building technology companies, focusing on early-stage ventures and fostering innovation.
Form Ventures
Form Ventures is an investment firm specializing in UK startups with public policy exposure, providing capital and strategic guidance to navigate regulatory landscapes and accelerate growth.
What's next for Thymia?
With its recent major strategic investment, Thymia is poised for significant expansion. The capital infusion is expected to fuel further development of its AI diagnostic tools, enhance its market reach, and potentially explore new therapeutic applications. This funding will likely enable Thymia to scale its operations, forge strategic partnerships within the healthcare ecosystem, and solidify its position as a leader in AI-powered mental wellness solutions. The company's trajectory suggests a strong focus on clinical validation and broader adoption by healthcare providers.
See full Thymia company page
